| Literature DB >> 33110835 |
Amit Kumar Singh1, Meenakshi Yeola1, Namrata Singh2, Smita Damke3.
Abstract
AIM: This study was carried out on patients with diabetic foot ulcer (DFU) to assess the clinical characteristics, spectrum of microbial flora, antibiotic sensitivity, and devise an empiric antimicrobial therapy. MATERIALEntities:
Keywords: Antibiotic sensitivity; Central India; diabetic foot ulcer; empiric treatment; infection
Year: 2020 PMID: 33110835 PMCID: PMC7586547 DOI: 10.4103/jfmpc.jfmpc_700_20
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Wagner’s grading of foot ulcers
| GRADE 0 | High risk foot, no ulcer |
|---|---|
| GRADE 1 | Superficial Ulcer, not clinically infected |
| GRADE 2 | Deeper ulcer, often with cellulitis, no abscess or bone infection. |
| GRADE 3 | Deep ulcer with abscess formation or bone involvement. |
| GRADE 4 | Localized gangrene |
| GRADE 5 | Gangrene of whole foot |
Distribution of bacterial isolates according to Gram stain and growth on culture media
| Tissue Culture | No. of isolates | Percentage (%) | |
|---|---|---|---|
| Gram-negative (73.7%) | 8 | 7.3 | |
| 30 | 27.3 | ||
| 5 | 4.5 | ||
| 17 | 15.5 | ||
| 8 | 7.3 | ||
| 13 | 11.8 | ||
| Gram-positive (27.3%) | 20 | 19.05 | |
| 5 | 4.5 | ||
| 4 | 3.81 |
Antibiotic sensitivity pattern of Gram-positive organisms
| Antibiotics | ||||||
|---|---|---|---|---|---|---|
| S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | |
| Amikacin | 20 (100%) | 0 (0%) | 5 (100%) | 0 (0%) | 4 (100%) | 0 (0%) |
| Ampicillin | 16 (80%) | 4 (20%) | 2 (40%) | 3 (60%) | 2 (50%) | 2 (50%) |
| Amoxicillin-clavulanic acid | 15 (75%) | 5 (25%) | 4 (80%) | 1 (20%) | 3 (75%) | 1 (25%) |
| Gentamicin | 20 (100%) | 0 (0%) | 5 (100%) | 0 (0%) | 4 (100%) | 0 (0%) |
| Erythromycin | 16 (80%) | 4 (20%) | 4 (80%) | 1 (20%) | 3 (75%) | 1 (25%) |
| Clindamycin | 14 (70%) | 6 (30%) | 3 (60%) | 2 (40%) | 2 (50%) | 2 (50%) |
| Ciprofloxacin | 16 (80%) | 4 (20%) | 3 (60%) | 2 (40%) | 3 (75%) | 1 (25%) |
| Ofloxacin | 18 (90%) | 2 (10%) | 4 (80%) | 1 (20%) | 4 (100%) | 0 (0%) |
| Vancomycin | 17 (85%) | 3 (15%) | 5 (100) | 0 (0%) | 3 (75%) | 1 (25%) |
| Methicillin | 14 (70%) | 6 (30%) | 2 (40%) | 3 (60%) | 3 (75%) | 1 (25%) |
Antibiotic sensitivity pattern of Gram-negative organisms
| S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amikacin | 26 (86.67%) | 4 (13.33%) | 15 (88.24%) | 2 (11.76%) | 13 (100%) | 0 (0%) | 8 (100%) | 0 (0%) | 3 (37.50%) | 5 (62.50%) | - | - |
| Ampicillin | 1 (3.33%) | 29 (96.67%) | 4 (23.53%) | 13 (76.47%) | 5 (38.46%) | 8 (61.54%) | 1 (12.50%) | 7 (87.50%) | - | - | - | - |
| Amox-clav* | 2 (6.67%) | 28 (93.33%) | 5 (29.41%) | 12 (70.59%) | 7 (53.85%) | 6 (46.15%) | 2 (25%) | 6 (75%) | 3 (37.50%) | 5 (62.50%) | 0 (0%) | 5 (100%) |
| Gentamicin | 25 (83.33%) | 5 (16.67%) | 13 (76.47%) | 4 (23.53%) | 11 (84.62%) | 2 (15.38%) | 7 (87.50%) | 1 (12.50%) | 2 (25%) | 6 (75%) | - | - |
| Ciproflox | 13 (43.3%) | 17 (56.67%) | 9 (52.94%) | 8 (47.06%) | 7 (53.85%) | 6 (46.15%) | 4 (50%) | 4 (50%) | 0 (0%) | 8 (100%) | - | - |
| Oflox | 14 (46.67%) | 16 (53.33%) | 12 (70.59%) | 5 (29.41%) | 9 (69.23%) | 4 (30.77%) | 6 (75%) | 2 (25%) | 3 (37.50%) | 5 (62.50%) | - | - |
| Ceftazidime | 21 (70%) | 9 (30%) | 14 (82.35%) | 3 (17.65%) | 10 (76.92%) | 3 (23.08%) | 6 (75%) | 2 (25%) | 2 (25%) | 6 (75%) | 3 (60%) | 2 (40%) |
| Ceftrioxone | 20 (66.67%) | 10 (33.33%) | 12 (70.59%) | 5 (29.41%) | 11 (84.62%) | 2 (15.38%) | 5 (62.50%) | 3 (37.50%) | 1 (12.50%) | 7 (87.50%) | - | - |
| Cefotaxim | 24 (80%) | 6 (20%) | 13 (76.47%) | 4 (23.53%) | 11 (84.62%) | 2 (15.38%) | 8 (100%) | 0 (0%) | - | - | - | - |
| Imipenem | 27 (90%) | 3 (10%) | 16 (94.12%) | 1 (5.88%) | 13 (100%) | 0 (0%) | 8 (100%) | 0 (0%) | - | - | - | - |
*Amoxicillin clavulanic acid